ARCHIVES

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

Amgen Announces Cochrane Findings: ESAs Increase Risk Of On-Study Death.

October 3, 2008

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

Letter: The Lesson From Dana-Farber

July 28, 1995

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

Ford Gets Temporary Funds Bill; House Committee Demands More Positions for NCI

June 27, 1975

Young Molecular Biologists Optimistic, Survey Finds

February 21, 1997